Zoetis Inc. (NYSE:ZTS) Receives Average Recommendation of “Buy” from Analysts

Shares of Zoetis Inc. (NYSE:ZTS) have received an average rating of “Buy” from the nine brokerages that are currently covering the stock, MarketBeat.com reports. Eight analysts have rated the stock with a buy rating and one has issued a strong buy rating on the company. The average 12 month target price among analysts that have issued a report on the stock in the last year is $217.11.

A number of equities analysts have issued reports on the company. Argus raised Zoetis to a “strong-buy” rating in a report on Friday, August 9th. Stifel Nicolaus reiterated a “buy” rating and issued a $200.00 price objective on shares of Zoetis in a report on Tuesday, August 27th. Piper Sandler lifted their target price on shares of Zoetis from $195.00 to $210.00 and gave the stock an “overweight” rating in a research report on Wednesday, August 14th. Finally, BTIG Research upped their price target on shares of Zoetis from $220.00 to $225.00 and gave the company a “buy” rating in a research report on Monday, August 12th.

Institutional Investors Weigh In On Zoetis

A number of institutional investors have recently modified their holdings of the company. Hohimer Wealth Management LLC lifted its holdings in shares of Zoetis by 1.2% in the fourth quarter. Hohimer Wealth Management LLC now owns 4,386 shares of the company’s stock worth $866,000 after buying an additional 52 shares in the last quarter. Asset Dedication LLC lifted its stake in Zoetis by 4.8% in the 2nd quarter. Asset Dedication LLC now owns 1,174 shares of the company’s stock worth $204,000 after purchasing an additional 54 shares in the last quarter. Angeles Wealth Management LLC boosted its holdings in Zoetis by 3.5% in the 4th quarter. Angeles Wealth Management LLC now owns 1,640 shares of the company’s stock valued at $324,000 after purchasing an additional 56 shares during the period. Forza Wealth Management LLC grew its position in shares of Zoetis by 1.8% during the 2nd quarter. Forza Wealth Management LLC now owns 3,313 shares of the company’s stock valued at $574,000 after purchasing an additional 58 shares in the last quarter. Finally, L. Roy Papp & Associates LLP increased its holdings in shares of Zoetis by 2.8% in the second quarter. L. Roy Papp & Associates LLP now owns 2,221 shares of the company’s stock worth $385,000 after purchasing an additional 60 shares during the period. 92.80% of the stock is owned by institutional investors.

Zoetis Trading Up 0.8 %

Shares of Zoetis stock opened at $195.74 on Wednesday. The firm’s 50 day moving average is $183.65 and its 200 day moving average is $174.15. The firm has a market capitalization of $88.68 billion, a PE ratio of 37.71, a price-to-earnings-growth ratio of 2.92 and a beta of 0.88. Zoetis has a 1 year low of $144.80 and a 1 year high of $201.92. The company has a current ratio of 3.45, a quick ratio of 2.09 and a debt-to-equity ratio of 1.32.

Zoetis (NYSE:ZTS) last posted its earnings results on Tuesday, August 6th. The company reported $1.56 earnings per share for the quarter, topping analysts’ consensus estimates of $1.49 by $0.07. Zoetis had a net margin of 26.29% and a return on equity of 50.67%. The firm had revenue of $2.36 billion for the quarter, compared to analysts’ expectations of $2.31 billion. During the same quarter in the previous year, the firm posted $1.41 earnings per share. The company’s revenue was up 8.3% on a year-over-year basis. Equities research analysts forecast that Zoetis will post 5.84 earnings per share for the current fiscal year.

About Zoetis

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.